Research and Markets: Global Antidepressants (Migraine) Forecasts and Opportunities to 2023

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/q27qb8/antidepressants) has announced the addition of the "Antidepressants (Migraine) - Forecast and Market Analysis to 2023" report to their offering.

By 2023, the migraine market will grow to $3.7 billion at a compound annual growth rate (CAGR) of 3.6%, with the US continuing to dominate the market as a result of higher drug prices and a large migraine population. Some of the new treatments are expected to target the key unmet needs but opportunities will remain for further treatment choices especially drugs that will offer an improved safety and side-effects profile.

Certain Antidepressants have been used for the treatment of migraine since the 1970s (Gomersall and Stuart, 1973). Several classes of antidepressants exist, each with a different mechanism of action. These include tricyclic antidepressants (TCAs), MAO inhibitors, selective serotonin reuptake inhibitors (SSRIs), and serotonin norepinephrine reuptake inhibitors (SNRIs). Although the mechanism by which antidepressants prevent migraine headache is unknown, improvement is independent from treating masked depression; the response occurs sooner than the antidepressive effect.

Scope

  • Overview of Migraine, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
  • Detailed information on Antidepressants including product description, safety and efficacy profiles as well as a SWOT analysis.
  • Sales forecast for Antidepressants for the top five countries from 2012 to 2023.
  • Sales information covered for the US, France, Italy, Spain and Japan.

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Disease Overview

4 Disease Management

5 Competitive Assessment

6 Antidepressants

7 Appendix

For more information visit http://www.researchandmarkets.com/research/q27qb8/antidepressants

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Central Nervous System